Jonathan McNeill
2023
In 2023, Jonathan McNeill earned a total compensation of $2.2M as Chief Business Officer at Dyne Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $230,880 |
---|---|
Option Awards | $522,287 |
Salary | $430,468 |
Stock Awards | $1,046,199 |
Other | $996 |
Total | $2,230,830 |
McNeill received $1M in stock awards, accounting for 47% of the total pay in 2023.
McNeill also received $230.9K in non-equity incentive plan, $522.3K in option awards, $430.5K in salary and $996 in other compensation.
Rankings
In 2023, Jonathan McNeill's compensation ranked 461st out of 3,006 executives tracked by ExecPay. In other words, McNeill earned more than 84.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 461 out of 3,006 | 85th |
Division Manufacturing | 265 out of 1,650 | 84th |
Major group Chemicals And Allied Products | 181 out of 918 | 80th |
Industry group Drugs | 178 out of 881 | 80th |
Industry Pharmaceutical Preparations | 111 out of 637 | 83rd |
Source: SEC filing on April 5, 2024.
McNeill's colleagues
We found two more compensation records of executives who worked with Jonathan McNeill at Dyne Therapeutics in 2023.